Graham Capital Management L.P. Grows Holdings in Doximity, Inc. $DOCS

Key Points

• Graham Capital Management L.P. has increased its holdings in Doximity, Inc. by 67.5%, now owning 56,392 shares worth approximately $3.27 million.
• Several hedge funds have invested in Doximity, with Vident Advisory increasing its position by 231.7% and now holding shares worth about $1.8 million.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Doximity, with a price target averaging around $66.21.

Graham Capital Management L.P. grew its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 67.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 56,392 shares of the company's stock after purchasing an additional 22,731 shares during the quarter. Graham Capital Management L.P.'s holdings in Doximity were worth $3,272,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in Doximity in the 1st quarter worth approximately $65,702,000. Vanguard Group Inc. increased its holdings in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after acquiring an additional 990,923 shares in the last quarter. Fundsmith LLP purchased a new stake in Doximity in the 4th quarter worth approximately $37,934,000. Invesco Ltd. increased its holdings in Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after acquiring an additional 696,923 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. increased its holdings in Doximity by 180.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 972,157 shares of the company's stock worth $51,903,000 after acquiring an additional 625,467 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Wall Street Analyst Weigh In

DOCS has been the subject of several analyst reports. KeyCorp increased their target price on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Truist Financial increased their target price on shares of Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a report on Thursday, July 17th. Robert W. Baird dropped their price target on Doximity from $87.00 to $65.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Raymond James Financial upped their price target on Doximity from $65.00 to $75.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Finally, William Blair restated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, Doximity currently has an average rating of "Moderate Buy" and an average price target of $66.21.

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $63.00, for a total value of $315,000.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director owned 6,360 shares of the company's stock, valued at approximately $381,600. This represents a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock worth $1,929,380 over the last three months. 31.30% of the stock is owned by insiders.

Doximity Price Performance

Shares of NASDAQ DOCS traded up $1.25 during midday trading on Thursday, reaching $68.55. 693,138 shares of the stock traded hands, compared to its average volume of 2,264,390. The stock has a market capitalization of $12.84 billion, a PE ratio of 68.55, a P/E/G ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a one year low of $35.32 and a one year high of $85.21. The company's 50 day moving average is $62.34 and its 200 day moving average is $60.17.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.